within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01B_Antimetabolites.L01BA05_Pralatrexate;

model Pralatrexate
  extends Pharmacolibrary.Drugs.ATC.L.L01BA05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L01BA05</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Pralatrexate is an antineoplastic agent and antifolate designed to accumulate preferentially in cancer cells. It inhibits dihydrofolate reductase (DHFR), disrupting DNA synthesis. Pralatrexate is primarily used for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL) and is approved for this indication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adults with relapsed or refractory peripheral T-cell lymphoma following a 30 mg/m2 dose administered intravenously over 3-5 minutes.</p><h4>References</h4><ol><li><p>Fury, MG, Krug, LM, Azzoli, CG, Sharma, S, Kemeny, N, Wu, N, Kris, MG, &amp; Rizvi, NA (2006). A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors. <i>Cancer chemotherapy and pharmacology</i> 57(5) 671–677. DOI:<a href=\"https://doi.org/10.1007/s00280-005-0080-x\">10.1007/s00280-005-0080-x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16136310/\">https://pubmed.ncbi.nlm.nih.gov/16136310</a></p></li><li><p>McPherson, JP, Vrontikis, A, Sedillo, C, Halwani, AS, &amp; Gilreath, JA (2016). Pralatrexate Monitoring Using a Commercially Available Methotrexate Assay to Avoid Potential Drug Interactions. <i>Pharmacotherapy</i> 36(2) e8–e11. DOI:<a href=\"https://doi.org/10.1002/phar.1699\">10.1002/phar.1699</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26809959/\">https://pubmed.ncbi.nlm.nih.gov/26809959</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Pralatrexate;
